TABLE 1.
Strain | Mean transmigrated PMNL eq ± SE (104):
|
|
---|---|---|
Without MAb anti-CD55 (1H4) | With MAb anti-CD55 (1H4) | |
Control (HBSS buffer) | 3.1 ± 1 | 2.2 ± 1 |
fMLP (10−7 M) | 23.2 ± 1.3 | 21.2 ± 0.5 |
Wild-type C1845 | 19.1 ± 2.1 | 3.5 ± 1.1* |
Wild-type IH11128 | 16.5 ± 1 | 2.8 ± 1* |
HB101/pSSS1 (F1845 adhesin) | 14.9 ± 0.5 | 3.4 ± 1.4* |
HB101 | 2.9 ± 1.2 | 2.4 ± 1 |
A positive control was performed with the PMNL transmigrating inducing peptide fMLP at 10−7 M. All wild-type Afa/Dr DAEC strains and recombinant HB101/pSSS1 harboring Afa/Dr DAEC F1845 adhesin elicited a transepithelial migration of PMNL (not significantly different between PMNL transepithelial migration induced by fMLP versus wild-type Afa/Dr DAEC strains harboring the fimbrial F1845 and Dr hemagglutinin and recombinant E. coli HB101/pSSS1 expressing F1845 adhesin). PMNL transepithelial migrations induced by wild-type Afa/Dr DAEC C1845 and IH11128 strains or HB101/pSSS1 E. coli are inhibited by intestinal epithelial cells preincubated with MAb anti-CD55 (1H4) (∗, <0.01) versus infection without MAb CD55. Data are pooled from 6 to 12 individual monolayers for each condition, and the results are means ± standard errors.